Recombinant Human OAZ1 Protein，His

The OAZ1 protein, or Ornithine Decarboxylase Antizyme 1, plays a crucial role in the regulation of polyamine synthesis, which is essential for cell growth and differentiation. Research has increasingly focused on OAZ1 due to its implications in various cellular processes and diseases, including cancer. In normal physiological conditions, OAZ1 acts as an inhibitor of Ornithine Decarboxylase (ODC), the enzyme responsible for the first step in polyamine biosynthesis. By regulating ODC activity, OAZ1 helps maintain cellular polyamine levels, which are vital for cellular functions such as DNA stabilization, cell proliferation, and apoptosis. Dysregulation of OAZ1 has been linked to tumorigenesis, making it a potential target for therapeutic interventions. Furthermore, OAZ1 exhibits a unique property of forming complexes with polyamines and other proteins, which underscores its multifunctional role in cellular signaling and metabolism. Recent advances in recombinant protein technology have enabled the production and characterization of OAZ1, facilitating in-depth studies of its structure, function, and interactions. Understanding the molecular mechanisms governing OAZ1 activity and its effect on polyamine metabolism may lead to novel strategies for cancer treatment and other diseases associated with altered polyamine levels. This growing body of research highlights the potential of OAZ1 not only as a biomarker for cancer progression but also as a promising target for drug development, emphasizing the importance of continued exploration into the therapeutic applications of this fascinating protein.